相关实验视频

Updated: Sep 16, 2025

Conversion of Human Induced Pluripotent Stem Cells iPSCs into Functional Spinal and Cranial Motor Neurons Using PiggyBac Vectors

Conversion of Human Induced Pluripotent Stem Cells iPSCs into Functional Spinal and Cranial Motor Neurons Using PiggyBac Vectors

Published on: May 1, 2019

鉴定诱导多能干细胞和来自携带不同突变的肌缩性侧面硬化症患者的神经祖先中的转录组差异:试点研究

Chiara Sgromo¹, Martina Tosi¹, Cristina Olgasi²

¹Department of Health Sciences, Università degli Studi del Piemonte Orientale, 28100 Novara, Italy.

|July 11, 2025

概括

这项研究产生了来自肌缩侧面硬化症 (ALS) 患者的诱导多能干细胞 (iPSC),以探索疾病机制. 研究结果揭示了细胞外矩阵在ALS进展和神经元通路缺陷中的重要性,突出了疾病的重要性.

科学领域:

神经科学是一个神经科学.
遗传学是一个遗传学.
干细胞生物学干细胞生物学

背景情况:

肌缩侧面硬化症 (ALS) 是一种复杂的神经退行性疾病,其分子基础不明确,具有显著的遗传和表型变异性.
了解ALS的分子基础对于开发有效的治疗策略至关重要.

研究的目的:

从已知遗传突变 (C9orf72,TARDBP,KIF5A) 的ALS患者和健康对照产生诱导多能干细胞 (iPSC).
研究ALS之间的转录组差异,控制iPSC和衍生神经圈,以确定疾病特异性的分子通路.
建立一个有价值的细胞模型来研究ALS病原和患者特异性变异性.

主要方法:

从ALS患者和健康捐赠者的外周血液生成iPSCs.
在RNA和蛋白质水平上对多能性标记物的iPSCs的表征.
将iPSCs分化为胚胎体和神经圈.
对iPSCs和神经圈进行转录组分析 (RNA测序),以确定差异表达基因 (DEGs).

主要成果:

iPSCs表现出典型的干细胞形态和标记物表达.
ALS iPSCs显示与细胞外基质相关的共享差异表达基因 (DEGs).
来自ALS的神经圈在神经通路中表现出广泛的缺陷,患者特异性的DEG变异.
这项研究成功地从具有不同遗传背景的ALS患者中生成了iPSC线.

结论:

细胞外基质在肌缩性侧面硬化症 (ALS) 的进展中起着重要作用.
ALS神经圈显示出显著的神经通路缺陷,强调了疾病的异质性.
生成的iPSC线条为剖析ALS分子机制和识别治疗点提供了强大的工具.

关键词:

肌缩性侧面硬化症 (AMLS) 是一种疾病.在RNA-seqqq.诱导多能干细胞的诱导干细胞.神经前代细胞的神经前代细胞转录组分析转录组分析

更多相关视频

Establishment of an Electrophysiological Platform for Modeling ALS with Regionally-Specific Human Pluripotent Stem Cell-Derived Astrocytes and Neurons

Establishment of an Electrophysiological Platform for Modeling ALS with Regionally-Specific Human Pluripotent Stem Cell-Derived Astrocytes and Neurons

Published on: August 26, 2021

Analyzing Mitochondrial Transport and Morphology in Human Induced Pluripotent Stem Cell-Derived Neurons in Hereditary Spastic Paraplegia

Analyzing Mitochondrial Transport and Morphology in Human Induced Pluripotent Stem Cell-Derived Neurons in Hereditary Spastic Paraplegia

Published on: February 9, 2020

相关概念视频

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...